SUZANNE BLANCHARD: Open Payments
NPI 1023015104 · PRUDENVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 19 payments from 8 companies in 2025. Trend: 2023 $392 · 2024 $541 · 2025 $360
Food & beverage: $328Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Lilly USA, LLC | 3 | $59 |
| Exact Sciences Corporation | 2 | $33 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, FARXIGA, Ozempic, Cologuard Collection Kit, OTEZLA, JARDIANCE.
Industry payments across MI — which companies pay providers there.
